Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LPT

Financiado

Cerrado

LPT Laser based Proton Therapy sysLPT Laser based Proton Therapy system Har...

LPT Laser based Proton Therapy sysLPT Laser based Proton Therapy system Harnessing High Intensity Lasers Physics for Cancer Treatment Proton Therapy Cancer is a global problem with 14.1 million new cases occurring annually and an expected increase of 68% by 2030. Ensuring effective and safe treatment remains a significant challenge for healthcare organisations. Studies have sh... ver más

30/11/2022

HIL APPLIED MEDICA...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

HIL APPLIED MEDICAL LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-11-30

EIC-FTI-2018-2020: Fast Track to Innovation (FTI)

I+D

Cerrada hace 6 años

0% 72% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

HIL APPLIED MEDICAL

1.69M€ | Lider

SOLPLAST

207.47K€ | Participante

THALES LAS FRANCE SAS

756.23K€ | Participante

Proyectos interesantes

HIL PT System

Medical Technol...

Applied Physics

3M€ Cerrado

PDC2022-133382-I00

Medical Technol...

Applied Physics

150K€ Cerrado

HIL PT System

Medical Technol...

Applied Physics

2M€ Cerrado

MSPrad

Medical Technol...

Applied Physics

225K€ Cerrado

HLPA

Medical Technol...

Applied Physics

166K€ Cerrado

PROTONMBRT

Medical Technol...

Applied Physics

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 24 meses Fecha Inicio: 2020-11-05
Fecha Fin: 2022-11-30

Líder del proyecto

HIL APPLIED MEDICAL LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is a global problem with 14.1 million new cases occurring annually and an expected increase of 68% by 2030. Ensuring effective and safe treatment remains a significant challenge for healthcare organisations. Studies have shown proton therapy to be effective in treating many types of tumours, including tumours of the prostate, brain, head and neck, central nervous system, lung, and gastrointestinal system as well as cancers that cannot be removed completely by surgery. Proton therapy is the most advanced type of external-beam radiation therapy that uses protons at high energy to destroy cancer cells. Proton therapy is routinely used for cancer treatment however it is limited by the sheer size and expense of the systems. There are currently only 66 operational proton therapy facilities in the world, addressing only 3-5% of clinical demand. LPT is developing a proton therapy system that overcomes the presented challenges, saving up to 50% space and reducing costs by up to 75%. LPT applies a patented approach to particle acceleration and beam delivery, combining nanotechnology with Nobel- Prizewinning ultra-high-intensity lasers and advanced magnetics. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems that will enable the widespread adoption of proton therapy both across Europe and globally. The technology is supported by the Horizon 2020, SME instrument. The LPT project aims to take the innovation to the next level through the collaboration of strong industrial and academia players. Together, HIL applied medical, THALES Optronique and INFN, will achieve fundamental milestones in the development of the commercial system, namely PT-100. This system will be constructed based on the Alpha system (developed with the support of SME instrument), with a higher repetition rate and proton flux to enable clinical use and wide market adoption.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores